Please use this identifier to cite or link to this item:
https://doi.org/10.1016/S0040-4039(03)01173-0
DC Field | Value | |
---|---|---|
dc.title | A divergent approach to apoptolidin and FD-891: Asymmetric preparation of a common intermediate | |
dc.contributor.author | Chng, S.-S. | |
dc.contributor.author | Xu, J. | |
dc.contributor.author | Loh, T.-P. | |
dc.date.accessioned | 2014-06-23T05:29:59Z | |
dc.date.available | 2014-06-23T05:29:59Z | |
dc.date.issued | 2003-06-30 | |
dc.identifier.citation | Chng, S.-S., Xu, J., Loh, T.-P. (2003-06-30). A divergent approach to apoptolidin and FD-891: Asymmetric preparation of a common intermediate. Tetrahedron Letters 44 (27) : 4997-5000. ScholarBank@NUS Repository. https://doi.org/10.1016/S0040-4039(03)01173-0 | |
dc.identifier.issn | 00404039 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/75408 | |
dc.description.abstract | Biologically active Apoptolidin and FD-891 have structural similarity in their macrocyclic cores. Asymmetric preparation of a common intermediate in the total synthesis of these two macrolides is presented. A modified Masuyama Sn-allylation was employed to control the relative stereochemistry in the synthesis of the intermediate. © 2003 Elsevier Science Ltd. All rights reserved. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/S0040-4039(03)01173-0 | |
dc.source | Scopus | |
dc.subject | Apoptolidin | |
dc.subject | Divergent synthesis | |
dc.subject | FD-891 | |
dc.type | Article | |
dc.contributor.department | CHEMISTRY | |
dc.description.doi | 10.1016/S0040-4039(03)01173-0 | |
dc.description.sourcetitle | Tetrahedron Letters | |
dc.description.volume | 44 | |
dc.description.issue | 27 | |
dc.description.page | 4997-5000 | |
dc.description.coden | TELEA | |
dc.identifier.isiut | 000183683500012 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.